What is N-acetylcysteine (NAC) and is it recommended as a supplement?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

N-acetylcysteine (NAC) is not universally recommended as a supplement for everyone, but it may be beneficial for certain conditions, particularly for patients with moderate to severe COPD and a history of two or more exacerbations in the previous 2 years, as it has been shown to reduce the number of exacerbations 1. NAC is a modified form of the amino acid cysteine that serves as a precursor to glutathione, an important antioxidant in the body. It's primarily used medically as a treatment for acetaminophen overdose and as a mucolytic agent to break up thick mucus in conditions like cystic fibrosis and COPD. As a supplement, NAC is sometimes taken for its antioxidant properties, potential immune support, and possible benefits for respiratory conditions. Typical supplement dosages range from 600-1800 mg daily, often divided into 2-3 doses. However, NAC supplementation should be approached with caution as it can cause side effects including nausea, vomiting, and diarrhea. It may also interact with certain medications, particularly blood thinners. Some key points to consider when deciding whether to take NAC as a supplement include:

  • The evidence for NAC's effectiveness for many popular uses is mixed, and its regulatory status has been somewhat controversial 1.
  • NAC has been shown to be effective in reducing the rate of exacerbations in COPD, with a reduction in the rate of exacerbations associated with the use of NAC 1.
  • The American College of Chest Physicians and Canadian Thoracic Society guideline suggests treatment with oral N-acetylcysteine to prevent acute exacerbations of COPD for patients with moderate to severe COPD and a history of two or more exacerbations in the previous 2 years 1. Before taking NAC as a supplement, it's advisable to consult with a healthcare provider to determine if it's appropriate for your specific health needs and circumstances.

From the FDA Drug Label

Acetylcysteine is the N-acetyl derivative of the naturally-occurring amino acid, L-cysteine. The compound is a white crystalline powder with the molecular formula C5H9NO3S, a molecular weight of 163. 2, and chemical name of N-acetyl-L-cysteine.

N-acetylcysteine is a derivative of the amino acid L-cysteine.

  • It is not recommended as a supplement in the provided drug labels.
  • The labels only discuss its use as an antidote for acetaminophen overdose and as a mucolytic agent 2, 2.

From the Research

What is N-Acetylcysteine

  • N-Acetylcysteine (NAC) is a medicine used to treat various medical conditions, including Tylenol overdose, cystic fibrosis, and chronic obstructive lung disease 3.
  • It has antioxidant and anti-inflammatory properties, which are used to treat diseases related to oxidative stress and inflammation 4.
  • NAC can increase the intracellular concentration of glutathione, a crucial biothiol responsible for cellular redox imbalance, and reduce levels of tumor necrosis factor-alpha and interleukins by suppressing the activity of nuclear factor kappa B 4.

Recommended Use as a Supplement

  • NAC may be useful as an adjuvant in treating various medical conditions, especially chronic diseases, such as polycystic ovary disease, male infertility, sleep apnea, and others 3.
  • Supplementation with NAC may contribute to reducing morbidity and mortality in some chronic conditions, particularly as the population ages and levels of glutathione drop 3.
  • However, the effectiveness of NAC in clinical trials addressing different pathological conditions is still limited, and more research is needed to fully understand its therapeutic potential 4.

Specific Conditions and Dosages

  • For chronic bronchitis or COPD exacerbations, NAC treatment may be effective in preventing exacerbations, with a dose of ≥ 1200 mg per day recommended for patients with airway obstruction, and 600 mg per day for those without airway obstruction 5.
  • A meta-analysis found that NAC reduced the frequency of chronic bronchitis exacerbations and improved symptoms, with a low dosage (< 1200 mg per day) and a duration of at least 3 months being effective 6.
  • However, not all studies have found NAC to be effective, and some have reported no significant benefits or increased risk of adverse effects 7.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

N-Acetylcysteine (NAC): Impacts on Human Health.

Antioxidants (Basel, Switzerland), 2021

Research

Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis.

European respiratory review : an official journal of the European Respiratory Society, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.